Literature DB >> 7442822

Selective inhibition by amezinium of intraneuronal monoamine oxidase.

A Steppeler, K Starke.   

Abstract

Intra- and extraneuronal compartments of rat hearts were selectively labelled by perfusion with 3H-noradrenaline in the presence of corticosterone 87 microM or cocaine 30 microM, respectively. The subsequent outflow of 3H-compounds was examined. As little as 1 nM amezinium diminished the outflow of intraneuronally formed 3H-DOPEG. This effect was antagonized by cocaine. Amezinium 1 microM was necessary to diminish the outflow of extraneuronally formed 3H-DOPEG. This effect was not counteracted by corticosterone. The results indicate that amezinium is both a potent and, at low concentrations, selective inhibitor of intraneuronal MAO.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7442822     DOI: 10.1007/bf00498426

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  The neuronal and extraneuronal distribution of 3H(-)-noradrenaline in the perfused rat heart.

Authors:  R Mekanontchai; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

2.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

3.  An analysis of the effects of amezinium on postganglionic sympathetic neurones.

Authors:  A Steppeler; R Pfändler; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

4.  False labelling of commercially available 3H-catecholamines?

Authors:  K Starke; A Steppler; A Zumstein; M Henseling; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

5.  Extraneuronal monoamine oxidase in rat heart: biochemical characterization and electron microscopic localization.

Authors:  M C Lowe; D D Reichenbach; A Horita
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

6.  The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.

Authors:  E R Fiebig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

7.  Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type.

Authors:  C Goridis; N H Neff
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

8.  Rat and human cardiac monoamine oxidase: a comparison with other tissues.

Authors:  E J Dial; D E Clarke
Journal:  Eur J Pharmacol       Date:  1979-10-01       Impact factor: 4.432

  8 in total
  15 in total

1.  Direct effect of amezinium on rabbit urethra: effect of estrogen and progesterone treatment.

Authors:  M Ishigooka; T Hashimoto; Y Suzuki; O Ichiyanagi; I Sasagawa; T Nakada
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Pharmacodynamic and pharmacokinetic evaluation in man of the new sympathomimetic amezinium.

Authors:  G Neugebauer; H S Kaumeier; O H Kehrhahn; H Morgenthaler
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Sympathomimetic effects of amezinium on the cardiovascular system and plasma catecholamines in man.

Authors:  G G Belz; P E Aust; G Belz; E Appel; D Palm
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats.

Authors:  L J Bryan-Lluka; H Seers; I Sharpe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

5.  Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro.

Authors:  A Zumstein; W Karduck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

6.  Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.

Authors:  M Q Paiva; M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

7.  Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.

Authors:  A L Ask; I Fagervall; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

8.  Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.

Authors:  S Lenzen; H Nahrstedt; U Panten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

9.  Metabolism of endogenous and exogenous noradrenaline in guinea-pig atria.

Authors:  K Starke; L Hedler; A Steppeler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

10.  Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.

Authors:  M M Caramona; J V Esplugues; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.